Skip to main content
. 2022 Nov;12(11):4990–5003. doi: 10.21037/qims-22-265

Figure 1.

Figure 1

Study flowchart. All consecutively patients from January 2012 to November 2018 who were treated at the Urology Department of our hospital and received complete and evaluable bpMRI of the prostate showing a suspicious lesion (PI-RADS ≥3) and obtained histopathologic report within 6 months as well as PSA within 4 weeks prior MRI were included in the study. bpMRI, biparametric MRI; PSA, prostate specific antigen; PI-RADS, Prostate Imaging Reporting and Data System.